SCHEMBL4727991

SCHEMBL4727991

Cc1ccc(Nc2nccc(NC(CO)c3ccccn3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 3/20 0.45
▸ CDK4 P11802 2/20 0.45
▸ PLK1 P53350 3/20 0.44
▸ AURKA O14965 6/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ CDK1 P06493 2/20 0.44
▸ CHEK1 O14757 1/20 0.44
▸ IKBKB O14920 1/20 0.44
▸ PDPK1 O15530 1/20 0.44
▸ CHEK2 O96017 1/20 0.44
▸ PRKCG P05129 1/20 0.44
▸ LYN P07948 1/20 0.44
▸ KIT P10721 1/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ FGFR1 P11362 1/20 0.44
▸ FGFR3 P22607 1/20 0.44
▸ RPS6KB1 P23443 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4730819 0.84 CDK2 (0.49) CDK2CDK4PLK1AURKANPC1
SCHEMBL4779934 0.84 AURKA (0.52) CDK2CDK4PLK1AURKANPC1
SCHEMBL4726184 0.81 CDK2 (0.44) CDK2CDK4PLK1AURKAMAPK1
SCHEMBL4727989 0.80 CDK2 (0.47) CDK2CDK4PLK1AURKANPC1
SCHEMBL4729983 0.78 PGR (0.45) CDK2CDK4PLK1AURKANPC1
SCHEMBL4727398 0.77 AURKA (0.52) CDK2CDK4PLK1AURKANPC1
SCHEMBL4725764 0.76 AURKA (0.51) CDK2CDK4PLK1AURKANPC1
SCHEMBL4779918 0.76 AURKA (0.52) AURKASYK
SCHEMBL4729366 0.75 SLC10A1 (0.36) CDK2PLK1MAPTMAPK1PIM1
SCHEMBL4727466 0.73 AURKA (0.52) CDK2PLK1AURKANPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008024634-A1 PYRIMDINE COMPOUNDS USEFUL AS KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-28 — — WO disclosed
Send feedback